Literature DB >> 24131167

A preliminary study on the effect of combined nicotine replacement therapy on alcohol responses and alcohol self-administration.

Tomoko Udo1, Emily L R Harrison, Julia Shi, Jeanette Tetrault, Sherry A McKee.   

Abstract

BACKGROUND AND OBJECTIVES: Limiting alcohol consumption may help prevent alcohol-mediated smoking relapse in heavy drinking smokers. This pilot study examined whether combining a nicotine patch with nicotine nasal spray has stronger attenuating effects on alcohol response and consumption than a nicotine patch alone.
METHODS: Twenty-two non-alcohol dependent heavy drinking smokers completed the double-blind cross-over, placebo-controlled study (21 mg nicotine patch + nicotine or placebo nasal spray). Six hours after 21 mg nicotine patch application, subjective and physiological responses to a priming drink (0.3 g/kg) were assessed, followed by two 1-hr alcohol self-administration periods, with possible consumption of up to 4 drinks per period (each 0.15 g/kg). Nasal spray (1 mg [active] or 0 mg [placebo] per dose) was administered 10 min prior to the priming dose and each self-administration period.
RESULTS: Active nasal spray did not increase serum nicotine levels, compared with placebo administration. The number of drinks consumed did not differ by the nasal spray conditions. However, positive subjective responses to the priming drink were lower in the active nasal spray condition than the placebo nasal spray condition. During the self-administration period, urge to drink was also lower in the active spray condition than the placebo condition. CONCLUSIONS AND SCIENTIFIC SIGNIFICANCE: Augmenting the nicotine patch with nicotine nasal spray attenuated positive subjective alcohol response and craving and suggests that future studies should investigate whether these findings translate to a clinical setting.
Copyright © American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24131167      PMCID: PMC3934424          DOI: 10.1111/j.1521-0391.2013.12014.x

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  34 in total

1.  Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings.

Authors:  L S Cox; S T Tiffany; A G Christen
Journal:  Nicotine Tob Res       Date:  2001-02       Impact factor: 4.244

2.  Alcohol consumption and quitting smoking in the International Tobacco Control (ITC) Four Country Survey.

Authors:  Christopher W Kahler; Ron Borland; Andrew Hyland; Sherry A McKee; Mary E Thompson; K Michael Cummings
Journal:  Drug Alcohol Depend       Date:  2008-12-03       Impact factor: 4.492

3.  Does heightened affect make smoking cues more salient?

Authors:  Saul Shiffman; Chad J Gwaltney
Journal:  J Abnorm Psychol       Date:  2008-08

4.  The effect of five smoking cessation pharmacotherapies on smoking cessation milestones.

Authors:  Sandra J Japuntich; Megan E Piper; Adam M Leventhal; Daniel M Bolt; Timothy B Baker
Journal:  J Consult Clin Psychol       Date:  2011-02

5.  Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics.

Authors:  Stevens S Smith; Danielle E McCarthy; Sandra J Japuntich; Bruce Christiansen; Megan E Piper; Douglas E Jorenby; David L Fraser; Michael C Fiore; Timothy B Baker; Thomas C Jackson
Journal:  Arch Intern Med       Date:  2009-12-14

6.  A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies.

Authors:  Megan E Piper; Stevens S Smith; Tanya R Schlam; Michael C Fiore; Douglas E Jorenby; David Fraser; Timothy B Baker
Journal:  Arch Gen Psychiatry       Date:  2009-11

7.  Effect of transdermal nicotine replacement on alcohol responses and alcohol self-administration.

Authors:  Sherry A McKee; Stephanie S O'Malley; Julia Shi; Tricia Mase; Suchitra Krishnan-Sarin
Journal:  Psychopharmacology (Berl)       Date:  2007-10-03       Impact factor: 4.530

8.  Varenicline reduces alcohol self-administration in heavy-drinking smokers.

Authors:  Sherry A McKee; Emily L R Harrison; Stephanie S O'Malley; Suchitra Krishnan-Sarin; Julia Shi; Jeanette M Tetrault; Marina R Picciotto; Ismene L Petrakis; Naralys Estevez; Erika Balchunas
Journal:  Biol Psychiatry       Date:  2009-02-27       Impact factor: 13.382

9.  Smoking cessation during alcohol treatment: a randomized trial of combination nicotine patch plus nicotine gum.

Authors:  Ned L Cooney; Judith L Cooney; Bridget L Perry; Michael Carbone; Emily H Cohen; Howard R Steinberg; David T Pilkey; Kevin Sevarino; Cheryl A Oncken; Mark D Litt
Journal:  Addiction       Date:  2009-06-22       Impact factor: 6.526

Review 10.  Nicotine replacement therapy for smoking cessation.

Authors:  L F Stead; R Perera; C Bullen; D Mant; T Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23
View more
  5 in total

1.  Young adults report increased pleasure from using e-cigarettes and smoking tobacco cigarettes when drinking alcohol.

Authors:  Johannes Thrul; Noah R Gubner; Chiara L Tice; Nadra E Lisha; Pamela M Ling
Journal:  Addict Behav       Date:  2019-01-16       Impact factor: 3.913

2.  Operant self-administration of alcohol and nicotine in a preclinical model of co-abuse.

Authors:  A D Lê; Douglas Funk; Steven Lo; Kathleen Coen
Journal:  Psychopharmacology (Berl)       Date:  2014-04-03       Impact factor: 4.530

3.  Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats.

Authors:  Sarah E Maggio; Meredith A Saunders; Thomas A Baxter; Kimberly Nixon; Mark A Prendergast; Guangrong Zheng; Peter Crooks; Linda P Dwoskin; Rachel D Slack; Amy H Newman; Richard L Bell; Michael T Bardo
Journal:  Psychopharmacology (Berl)       Date:  2018-02-18       Impact factor: 4.530

4.  An improved model of ethanol and nicotine co-use in female P rats: Effects of naltrexone, varenicline, and the selective nicotinic α6β2* antagonist r-bPiDI.

Authors:  Sarah E Maggio; Meredith A Saunders; Kimberly Nixon; Mark A Prendergast; Guangrong Zheng; Peter A Crooks; Linda P Dwoskin; Richard L Bell; Michael T Bardo
Journal:  Drug Alcohol Depend       Date:  2018-10-17       Impact factor: 4.492

5.  A novel human laboratory alcohol self-administration paradigm for medication screening: Modeling the ability to resist drinking and heavy drinking.

Authors:  Sherry A McKee; Terril L Verplaetse
Journal:  Drug Alcohol Depend Rep       Date:  2022-08-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.